[ad_1]
norththis Tuesday night, the pharmaceutical company AstraZeneca announced the suspension of vaccine trials for COVID-19-19 which is being developed in collaboration with the University of Oxford. Quoted by CNBC and to StatNews, the company explained that the suspension was motivated by a reaction serious adverse effect in one of the study participants.
Little is known about what happened, specifically, with the volunteer. But, according to The New York Times, a person had problems related to a congenital disease: myelite transversal, but it is not clear if it is the same person who reactions adverse events, whether the case is actually related to the vaccine or is purely coincidental.
Note: Ao The New York Times, a AstraZeneca declined to comment on the participant’s location and did not confirm the diagnosis of myelite transverse.
Which is the myelite transverse?
A myelite Transverse is a disease of the spinal cord, with potentially serious consequences. It can result from a number of causes that trigger inflammatory responses in the body, including infections viral.
Symptoms include muscle weakness, paralysis, numbness or discomfort in the nerves, pain neuropathic, spasms, among others. It can be sharp or develop slowly. The condition can usually be treated with steroids.
Read also: AstraZeneca stop the vaccine test after reaction adverse in voluntary
Always be the first to know.
Follow the chosen site for the fourth consecutive year Consumer Choice.
Download our free app.
[ad_2]
